Benzinga's Top #PreMarket Losers - Cyclacel Pharmaceuticals (NASDAQ:CYCC), Halozyme Therapeutics (NASDAQ:HALO)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Halozyme Therapeutics (NASDAQ: HALO) fell 23.73% to $8.84 in pre-market trading after the company announced the temporary halt of Phase 2 trial enrollment.Ocean Power Technologies (NASDAQ: OPTT) dipped 17.89% to $3.12 in the pre-market session after the company announced a proposed public offering of common stock. CarMax (NYSE: KMX) shares dropped 5.38% to $45.00 in pre-market trading after the company reported downbeat Q4 results and lifted its share-buyback authorization by $1 billion.Cyclacel Pharmaceuticals (NASDAQ: CYCC) dipped 4.85% to $3.53 in pre-market trading after the company priced an underwritten public offering of 2.857 million shares at $3.50 per share.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!